Literature DB >> 12852950

High throughput screening identifies novel inhibitors of Escherichia coli dihydrofolate reductase that are competitive with dihydrofolate.

Michela Zolli-Juran1, Jonathan D Cechetto, Rebecca Hartlen, Denis M Daigle, Eric D Brown.   

Abstract

This communication describes the high-throughput screen of a diverse library of 50,000 small molecules against Escherichia coli dihydrofolate reductase to detect inhibitors. Sixty-two compounds were identified as having significant inhibitory activity against the enzyme. Secondary screening of these revealed twelve molecules that were competitive with dihydrofolate, nine of which have not been previously characterized as inhibitors of dihydrofolate reductase. These novel molecules ranged in potency (K(i)) from 26 nM to 11 microM and may represent fresh starting points for new small molecule therapeutics directed against dihydrofolate reductase.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12852950     DOI: 10.1016/s0960-894x(03)00480-3

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  15 in total

1.  Here be dragons: docking and screening in an uncharted region of chemical space.

Authors:  Ruth Brenk; John J Irwin; Brian K Shoichet
Journal:  J Biomol Screen       Date:  2005-09-16

2.  Small molecules with antimicrobial activity against E. coli and P. aeruginosa identified by high-throughput screening.

Authors:  R De La Fuente; N D Sonawane; D Arumainayagam; A S Verkman
Journal:  Br J Pharmacol       Date:  2006-09-18       Impact factor: 8.739

3.  Insights into the slow-onset tight-binding inhibition of Escherichia coli dihydrofolate reductase: detailed mechanistic characterization of pyrrolo [3,2-f] quinazoline-1,3-diamine and its derivatives as novel tight-binding inhibitors.

Authors:  Bharath Srinivasan; Jeffrey Skolnick
Journal:  FEBS J       Date:  2015-03-06       Impact factor: 5.542

4.  Direct detection of structurally resolved dynamics in a multiconformation receptor-ligand complex.

Authors:  Mary J Carroll; Anna V Gromova; Keith R Miller; Hao Tang; Xiang Simon Wang; Ashutosh Tripathy; Scott F Singleton; Edward J Collins; Andrew L Lee
Journal:  J Am Chem Soc       Date:  2011-04-06       Impact factor: 15.419

5.  High-throughput screening for human lysosomal beta-N-Acetyl hexosaminidase inhibitors acting as pharmacological chaperones.

Authors:  Michael B Tropak; Jan E Blanchard; Stephen G Withers; Eric D Brown; Don Mahuran
Journal:  Chem Biol       Date:  2007-02

6.  A small-molecule screen identifies the antipsychotic drug pimozide as an inhibitor of Listeria monocytogenes infection.

Authors:  Linda A Lieberman; Darren E Higgins
Journal:  Antimicrob Agents Chemother       Date:  2008-11-17       Impact factor: 5.191

7.  Identification of pharmacological chaperones for Gaucher disease and characterization of their effects on beta-glucocerebrosidase by hydrogen/deuterium exchange mass spectrometry.

Authors:  Michael B Tropak; Gregory J Kornhaber; Brigitte A Rigat; Gustavo H Maegawa; Justin D Buttner; Jan E Blanchard; Cecilia Murphy; Steven J Tuske; Stephen J Coales; Yoshitomo Hamuro; Eric D Brown; Don J Mahuran
Journal:  Chembiochem       Date:  2008-11-03       Impact factor: 3.164

8.  Identification of selective inhibitors of the potassium channel Kv1.1-1.2((3)) by high-throughput virtual screening and automated patch clamp.

Authors:  Sören J Wacker; Wiktor Jurkowski; Katie J Simmons; Colin W G Fishwick; A Peter Johnson; David Madge; Erik Lindahl; Jean-Francois Rolland; Bert L de Groot
Journal:  ChemMedChem       Date:  2012-03-30       Impact factor: 3.466

9.  Evidence for dynamics in proteins as a mechanism for ligand dissociation.

Authors:  Mary J Carroll; Randall V Mauldin; Anna V Gromova; Scott F Singleton; Edward J Collins; Andrew L Lee
Journal:  Nat Chem Biol       Date:  2012-01-15       Impact factor: 15.040

10.  Virtual Screening as a Technique for PPAR Modulator Discovery.

Authors:  Stephanie N Lewis; Josep Bassaganya-Riera; David R Bevan
Journal:  PPAR Res       Date:  2009-09-02       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.